SBIR/STTR Research Award

Computational Methods for Functional Genomic Discovery from Gene Knockout Studies

Award identifier e6b3c211a196a53b8756cccf6610d571752f236d3d8b47039f4e5bc2a27a2520Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$158,485

Program and phase

SBIR · Phase I

Award year

2008

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
SERALOGIX, LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
D7MWZCNGG1D5
Solicitation number
PHS2007-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): The overall Phase I objective is to prototype a new computational tool to assess the feasibility of identifying and predicting gene functional and interactive relationships from gene expression data obtained from multi - comparative gene knockout studies. NIH's Knockout Mouse Project is an initiative to generate a public resource of mouse embryonic stem (ES) cells containing a null mutation in every gene in the mouse genome, important for the study of diseases and for de ciphering the complexity of biological systems of mice and ultimately in man. It is anticipated that a new generation of comparative knockout studies with a biological will emerge in all areas of biomedical research. Having new computational methods for id entifying and deciphering genetically regulated response (e.g. signaling cascades) will significantly aid in advancing our understanding of the molecular targets and mechanisms of many diseases and will be extremely important for making medical breakthroug hs, especially for the safe and effective development of drugs and diagnostics. Today, researchers are hindered by the tremendous volumes of data generated from knockout investigations. Seralogix plans to build upon the capabilities of our existing Biosyst em Analysis Framework (BAF) that is comprised of a suite of integrated analysis and mathematical modeling tools for gene and protein analysis. Our core tools are based on the statistical power of Dynamic Bayesian Networks (DBNs) that is built on sound stat istical methods that allow us to combine prior knowledge with empirical time-course data for modeling, pattern recognition and genetic network inference. Our innovation, proposed herein, is to integrate the multi- perturbation Shapley Value Analysis (MSA) method with our DBNs for improved genetic network discovery. MSA is based on concepts from game theory that we will utilized to identify the relationships/importance of each element (genes) in a system with respect to all other elements. We hypothesize th at MSA integrated with our DBN inference engine in conjunction with time-course gene expression data from multiple gene KO experiments will result in improved genetic interactive discovery leading to a more robust mathematical/functional model system. If s uccessful, the inclusion of MSA into Seralogix's suite of analysis and modeling tools will provide an important new tool for genetic functional and interactive relationship discovery. Seralogix believes that such a new tool will have significant commercial potential and will make a major contribution to the scientific community at large. The Phase I goals for our proposed tool will be to: 1) design and implement our DBN/MSA multi-conditional KO comparative methodology for discovery of underlying genetic net works; and 2) demonstrate proof-of-feasibility of the DBN/MSA methodology on mice gene KO expression data for folate receptor and related signaling pathways provided to us from the Texas Institute of Genomic Medicine (TIGM) as part of their ongoing birth d efect research. It is one of the ultimate goals for modern biological research to fully elucidate the intricate interplays and the regulations of the molecular determinants that control health and disease, to name a few, cell cycling, developmental biology , aging, and the progressive and recurrent pathogenesis of complex diseases. Having new computational methods (software tools) for identifying and deciphering genetically regulated response (e.g. signaling cascades) will significantly aid in advancing our understanding of the molecular targets and mechanisms of many diseases of high public health concern. The discovery of underlying genetic function and relationships will be extremely important for making medical breakthroughs, especially for the safe and e ffective development of drugs and diagnostics. Today, researchers are hindered by the tremendous volumes of gene/protein expression data generated from knoc

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

9 SBIR/STTR records share this UEI (2003–2017). Reported award amounts total $5,833,795. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.